NPPA fixes ceiling prices for 84 drug formulations; focus on Empagliflozin-based Diabetes therapies Ruchika Sharma8 May 2025 2:14 PM ISTNew Delhi: In a fresh directive aimed at curbing treatment costs and improving access to essential medicines, the National Pharmaceutical Pricing...
Drug Alert: 47 Drug Samples Fail To Clear CDSCO Test, 1 Declared spurious Susmita Roy31 March 2025 2:08 PM ISTNew Delhi: With an aim to make stakeholders aware of the not-of-standard-quality (NSQ) batches identified in the market, in its latest drug alert, the...
Windlas Biotech Gets CDSCO Panel Nod To study Bisoprolol Fumarate, Telmisartan, Chlorthalidone FDC Dr. Divya Colin26 March 2025 6:15 PM ISTNew Delhi: Windlas Biotech has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
NPPA Sets New Retail Price for Cilnidipine, Telmisartan Combination Farhat Nasim14 Feb 2025 4:41 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers, has revised the retail price of the...
NPPA Fixes Prices of 42 Popular Drugs Including Empagliflozin & Metformin, Dapagliflozin & Glimepiride; Details Farhat Nasim12 Feb 2025 8:31 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 42 essential drugs,...
Glenmark's Win: NPPA revises price of Telmisartan, Cilnidipine FDC after data review Farhat Nasim3 Dec 2024 2:57 PM ISTNew Delhi: Drug maker, Glenmark Pharmaceuticals' appeal against the earlier price fixation for its cardiovascular drug combination, Cilnidipine 20 mg...
Bisoprolol, Telmisartan, Chlorthalidone FDC: CDSCO asks Windlas Biotech to submit new BE protocol Dr. Divya Colin10 Oct 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has opined Windlas Biotech to...
Dr. Reddy's Laboratories Gets CDSCO Panel Nod to Study FDC Telmisartan Plus Chlortalidone for Export purpose only Dr. Divya Colin23 Sept 2024 6:00 PM ISTNew Delhi: The drug major Dr Reddy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO declares 5 formulations as spurious: Details Dr. Divya Colin17 Jun 2024 6:00 PM ISTNew Delhi: In the latest spurious drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has declared 5...
Hypertension Management in Pre- and Post- Percutaneous Coronary Intervention - An Expert Opinion MD Brand Connect10 Jun 2024 11:00 AM ISTAngiotensin receptor blockers (ARBs) are the most preferred antihypertensive agents among Indian cardiologists for managing hypertension in...
Justify Sample Size: CDSCO Panel Tells Windlas Biotech on Cardiovascular FDC Dr. Divya Colin19 May 2024 5:45 PM ISTNew Delhi: Reviewing the bioequivalence (BE) study report of the fixed-dose combination (FDC) of cardiovascular drug Bisoprolol Fumarate...
Ajanta Pharma Gets CDSCO Panel Nod To Study Antihypertensive FDC Dr. Divya Colin25 Nov 2023 6:00 PM ISTNew Delhi: Ajanta Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
